Author：Luye Life Sciences
Liu Dianbo, Chairman and President of Luye Life Sciences Group, recently attended the 10th Cleveland Clinic International Leadership Board meeting held in Switzerland.
At the meeting, Chairman Liu and Tom Miheljevic, CEO of Cleveland Clinic, together signed a memorandum outlining the establishment of The Luye Life Sciences Fund for Congenital Heart Care at Cleveland Clinic, a fund aimed at supporting physician training and child care in the field of congenital heart disease in China.
The Luye Life Sciences Fund for Congenital Heart Care at Cleveland Clinic will be established to support two initiatives.
The first is The Luye Life Sciences Endowed Chair in Congenital Heart Surgery, which aims to provide financial support to the training of Chinese surgeons at Cleveland Clinic for congenital heart disease surgery.
The second is The Luye Life Sciences Charitable Care Fund, which will provide financial support to Chinese children with severe congenital heart disease receiving treatment at Cleveland Clinic.
Both projects will be implemented through Cleveland Clinic’s Children’s Center, currently under the leadership of Dr. Hani Najm, who will also be appointed the initial chair holder of the Luye Life Sciences Endowed Chair in Congenital Heart Surgery.
Congenital heart disease is one of the most common congenital diseases found in children. In China, the number of new congenital heart disease cases among children is as high as 150,000 to 200,000 each year. According to data from the China Red Cross Foundation, currently millions of children across the country are living with congenital heart disease, and though most of them could be cured with surgery, due to delayed screening and the high cost of such surgery, many children with congenital heart disease are yet to receive treatment.
Speaking about the establishment of the fund, Chairman Liu Dianbo said，Luye Life Sciences is delighted to be working together with Cleveland Clinic, a globally renowned medical institution for the treatment of cardiovascular diseases, to improve the treatment of congenital heart disease in China and to help more Chinese children get timely treatment. Luye Life Sciences Group will continue to take a patient-centric approach while providing innovative medicines and value-based healthcare services to patients worldwide, and working closely with Cleveland Clinic to build future hospitals in China.
At the board meeting, Bill Peacock, COO of Cleveland Clinic, introduced the new hospitals being established under Cleveland Clinic's connected projects, located in Florida, London and Abu Dhabi, as well as the Shanghai Luye Lilan Hospital at Shanghai New Hongqiao International Medical Center. Sir Norman Foster, the 84 year old founder of Foster+Paterner, one of the world's top architectural design companies, presented the architectural design for the Shanghai Luye Lilan Hospital at the meeting.